Azathioprine Compared to Mycophenolate Mofetil Treatment in Patients with Interstitial Lung Disease Associated with Systemic Sclerosis

被引：0
|
作者：
Shell, J. [1 ]
Kapralik, J. [2 ]
Jones, A. [3 ]
Farooqi, M. [2 ]
Beattie, K. [4 ]
Kolb, M. R. [2 ]
Cox, G. P. [2 ]
Scallan, C. J. [5 ]
Larche, M. J. [4 ]
Khalidi, N. A. [4 ]
Hambly, N. [5 ]
机构：
[1] McMaster Univ, Dept Med, Hamilton, ON, Canada
[2] McMaster Univ, Div Respirol, Dept Med, Hamilton, ON, Canada
[3] McMaster Univ, Dept Hlth Res Methods, Hamilton, ON, Canada
[4] McMaster Univ, Div Rheumatol, Dept Med, Hamilton, ON, Canada
[5] McMaster Univ, Respirol, Hamilton, ON, Canada
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1915
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Mycophenolate mofetil for the treatment of systemic sclerosis
    Naik, Manisha
    Shenin, Max
    Derk, Chris T.
    LETTERS IN DRUG DESIGN & DISCOVERY, 2008, 5 (02) : 134 - 136
  • [22] Rituximab as a rescue treatment added on mycophenolate mofetil background therapy in progressive systemic sclerosis associated interstitial lung disease unresponsive to conventional immunosuppression
    Narvaez, Javier
    LLuch, Judit
    Molina-Molina, Maria
    Vicens-Zygmunt, Vanesa
    Luburich, Patricio
    Anibal Yanez, Marcos
    Nolla, Joan M.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2020, 50 (05) : 977 - 987
  • [23] Comparative effectiveness of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease
    Gkiouras, Konstantinos
    Grammatikopoulou, Maria G.
    Simopoulou, Theodora
    Daniil, Zoe
    Bogdanos, Dimitrios P.
    CLINICAL RHEUMATOLOGY, 2021, 40 (08) : 3379 - 3380
  • [24] Comparative effectiveness of mycophenolate mofetil versus cyclophosphamide in systemic sclerosis-related interstitial lung disease
    Konstantinos Gkiouras
    Maria G. Grammatikopoulou
    Theodora Simopoulou
    Zoe Daniil
    Dimitrios P. Bogdanos
    Clinical Rheumatology, 2021, 40 : 3379 - 3380
  • [25] Mycophenolate Mofetil for Interstitial Lung Disease in Dermatomyositis
    Morganroth, Pamela A.
    Kreider, Mary Elizabeth
    Werth, Victoria P.
    ARTHRITIS CARE & RESEARCH, 2010, 62 (10) : 1496 - 1501
  • [26] A RANDOMIZED CONTROLLED TRIAL TO COMPARE THE EFFICACY OF TACROLIMUS WITH MYCOPHENOLATE MOFETIL IN PATIENTS WITH SYSTEMIC SCLEROSIS - INTERSTITIAL LUNG DISEASE (INSIST TRIAL)
    Mathew, J.
    Kopp, C.
    Sharma, S. K.
    Dhir, V.
    Dhooria, S.
    Sinha, A.
    Jain, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 160 - 160
  • [27] Mycophenolate mofetil for interstitial lung disease in scleroderma
    Plastiras, S. C.
    Vlachoyiannopoulos, P. G.
    Tzelepis, G. E.
    RHEUMATOLOGY, 2006, 45 (12) : 1572 - 1572
  • [28] Interstitial lung disease treated with mycophenolate mofetil
    Megan Cully
    Nature Reviews Rheumatology, 2013, 9 (4) : 198 - 198
  • [29] Treatment of systemic sclerosis-associated interstitial lung disease
    Prasse, A.
    Bonella, F.
    Mueller-Ladner, U.
    Witte, T.
    Hunzelmann, N.
    Distler, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (03): : 294 - 303
  • [30] Treatment for systemic sclerosis-associated interstitial lung disease
    Roofeh, David
    Lescoat, Alain
    Khanna, Dinesh
    CURRENT OPINION IN RHEUMATOLOGY, 2021, 33 (03) : 240 - 248
12345